-
1
-
-
62949168411
-
-
European cardiovascular disease statistics Last update 14 Feb 2008 accessed 29 Feb 2008
-
European cardiovascular disease statistics 2008. European Heart Network. Last update 14 Feb 2008. Available at: http:// www.ehnheart.org/files/ statistics%202008%20web-161229A. pdf (accessed 29 Feb 2008).
-
(2008)
European Heart Network
-
-
-
2
-
-
35148892823
-
European guidelines on cardiovascular disease prevention in clinical practice: Executive summary
-
Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J. 2007;28:2375-2414
-
(2007)
Eur Heart J
, vol.28
, pp. 2375-2414
-
-
Graham, I.1
Atar, D.2
Borch-Johnsen, K.3
Boysen, G.4
Burell, G.5
Cifkova, R.6
-
3
-
-
70350476998
-
Clinical reality of coronary prevention in Europe: A comparison of EUROASPIRE I, II and III surveys. Time trends in cardiovascular disease prevention in clinical practice September
-
March 2007 press releases. Last update 2 Sep 2007 accessed 10 Oct 2007
-
Wood D. Clinical reality of coronary prevention in Europe: A comparison of EUROASPIRE I, II and III surveys. Time trends in cardiovascular disease prevention in clinical practice September 1994-March 2007. ESC Congress 2007 press releases. Last update 2 Sep 2007. Available at: http:// www.escardio.org/vpo/press + area/2007-esc-congress-pr/wo od-euroaspire.htm (accessed 10 Oct 2007).
-
(1994)
ESC Congress 2007
-
-
Wood, D.1
-
4
-
-
37149057185
-
Achievement of guideline-defined treatment goals in primary care: The German Coronary Risk Management (CoRiMa) study
-
Geller JC, Cassens S, Brosz M, Keil U, Bernarding J, Kropf S, et al. Achievement of guideline-defined treatment goals in primary care: the German Coronary Risk Management (CoRiMa) study. Eur Heart J. 2007;28:3051-3058
-
(2007)
Eur Heart J
, vol.28
, pp. 3051-3058
-
-
Geller, J.C.1
Cassens, S.2
Brosz, M.3
Keil, U.4
Bernarding, J.5
Kropf, S.6
-
5
-
-
26244432388
-
Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
-
Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267-1278
-
(2005)
Lancet
, vol.366
, pp. 1267-1278
-
-
Baigent, C.1
Keech, A.2
Kearney, P.M.3
Blackwell, L.4
Buck, G.5
Pollicino, C.6
-
6
-
-
42649102640
-
An update on regional variation in cardiovascular mortality within Europe
-
Muller-Nordhorn J, Binting S, Roll S, Willich SN. An update on regional variation in cardiovascular mortality within Europe. Eur Heart J. 2008;29:1316-1326
-
(2008)
Eur Heart J
, vol.29
, pp. 1316-1326
-
-
Muller-Nordhorn, J.1
Binting, S.2
Roll, S.3
Willich, S.N.4
-
7
-
-
33644932647
-
Levels of dyslipidaemia and improvement in its management in England: Results from the Health Survey for England
-
Primatesta P, Poulter NR. Levels of dyslipidaemia and improvement in its management in England: results from the Health Survey for England 2003. Clin Endocrinol (Oxf). 2006;64:292-298
-
(2003)
Clin Endocrinol (Oxf).
, vol.2006
, Issue.64
, pp. 292-298
-
-
Primatesta, P.1
Poulter, N.R.2
-
8
-
-
34147165075
-
Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: Data from National Health and Nutrition Examination Survey 1999 to 2002
-
Keevil JG, Cullen MW, Gangnon R, McBride PE, Stein JH. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002. Circulation. 2007;115:1363-1370
-
Circulation
, vol.2007
, Issue.115
, pp. 1363-1370
-
-
Keevil, J.G.1
Cullen, M.W.2
Gangnon, R.3
McBride, P.E.4
Stein, J.H.5
-
9
-
-
0037472879
-
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
-
DOI 10.1056/NEJMoa021778
-
Gaede P, Vedel P, Larsen N, Jensen G, Parving H, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383-393 (Pubitemid 36159355)
-
(2003)
New England Journal of Medicine
, vol.348
, Issue.5
, pp. 383-393
-
-
Gaede, P.1
Vedel, P.2
Larsen, N.3
Jensen, G.V.H.4
Parving, H.-H.5
Pedersen, O.6
-
10
-
-
9444245001
-
Intensive integrated therapy of type 2 diabetes: Implications for long-term prognosis
-
Gaede P, Pedersen O. Intensive integrated therapy of type 2 diabetes: implications for long-term prognosis. Diabetes. 2004;53 Suppl 3:S39-7.
-
(2004)
Diabetes
, vol.53
, Issue.SUPPL. 3
-
-
Gaede, P.1
Pedersen, O.2
-
11
-
-
26444552464
-
Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997
-
Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol. 2005;162:764-773
-
(2005)
Am J Epidemiol
, vol.162
, pp. 764-773
-
-
Laatikainen, T.1
Critchley, J.2
Vartiainen, E.3
Salomaa, V.4
Ketonen, M.5
Capewell, S.6
-
12
-
-
0037102131
-
Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE)
-
Steg PG, Goldberg RJ, Gore JM, Fox KA, Eagle KA, Flather MD, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol. 2002;90:358-363
-
(2002)
Am J Cardiol
, vol.90
, pp. 358-363
-
-
Steg, P.G.1
Goldberg, R.J.2
Gore, J.M.3
Fox, K.A.4
Eagle, K.A.5
Flather, M.D.6
-
13
-
-
0842346319
-
Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events (GRACE))
-
Goldberg RJ, Currie K, White K, Brieger D, Steg PG, Goodman SG, et al. Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events (GRACE)). Am J Cardiol. 2004;93:288-293
-
(2004)
Am J Cardiol
, vol.93
, pp. 288-293
-
-
Goldberg, R.J.1
Currie, K.2
White, K.3
Brieger, D.4
Steg, P.G.5
Goodman, S.G.6
-
14
-
-
0037524291
-
Effectiveness of statin titration on low-density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic events
-
Foley KA, Simpson RJ Jr, Crouse JR 3rd, Weiss TW, Markson LE, Alexander CM. Effectiveness of statin titration on low-density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic events. Am J Cardiol. 2003;92:79-81.
-
(2003)
Am J Cardiol
, vol.92
, pp. 79-81
-
-
Foley, K.A.1
Simpson Jr., R.J.2
Crouse III, J.R.3
Weiss, T.W.4
Markson, L.E.5
Alexander, C.M.6
-
15
-
-
33646750506
-
Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction
-
Gislason GH, Rasmussen JN, Abildstrom SZ, Gadsboll N, Buch P, Friberg J, et al. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J. 2006;27:1153-1158
-
(2006)
Eur Heart J
, vol.27
, pp. 1153-1158
-
-
Gislason, G.H.1
Rasmussen, J.N.2
Abildstrom, S.Z.3
Gadsboll, N.4
Buch, P.5
Friberg, J.6
-
16
-
-
41449103034
-
A critical gap between recommended and achieved LDL-cholesterol levels. Results of statin therapy in Slovakia
-
Gajdos M, Krivosikova Z, Uhliar R. A critical gap between recommended and achieved LDL-cholesterol levels. Results of statin therapy in Slovakia. Bratisl Lek Listy. 2007;108:388-392
-
(2007)
Bratisl Lek Listy
, vol.108
, pp. 388-392
-
-
Gajdos, M.1
Krivosikova, Z.2
Uhliar, R.3
-
17
-
-
18344368202
-
Failure to achieve recommended LDL cholesterol levels by suboptimal statin therapy relates to elevated cardiac event rates
-
Baessler A, Fischer M, Huf V, Mell S, Hengstenberg C, Mayer B, et al. Failure to achieve recommended LDL cholesterol levels by suboptimal statin therapy relates to elevated cardiac event rates. Int J Cardiol. 2005;101:293-298
-
(2005)
Int J Cardiol
, vol.101
, pp. 293-298
-
-
Baessler, A.1
Fischer, M.2
Huf, V.3
Mell, S.4
Hengstenberg, C.5
Mayer, B.6
-
18
-
-
34547772153
-
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes
-
Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28:1598-1660
-
(2007)
Eur Heart J
, vol.28
, pp. 1598-1660
-
-
Bassand, J.P.1
Hamm, C.W.2
Ardissino, D.3
Boersma, E.4
Budaj, A.5
Fernandez-Aviles, F.6
-
19
-
-
33846414720
-
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary the Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
-
Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;28:88-136.
-
(2007)
Eur Heart J
, vol.28
, pp. 88-136
-
-
Ryden, L.1
Standl, E.2
Bartnik, M.3
Van Den Berghe, G.4
Betteridge, J.5
De Boer, M.J.6
-
20
-
-
33745683654
-
Guidelines on the management of stable angina pectoris: Executive summary - The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology
-
DOI 10.1093/eurheartj/ehl001
-
Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, et al. Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J. 2006;27:1341-1381 (Pubitemid 43998110)
-
(2006)
European Heart Journal
, vol.27
, Issue.11
, pp. 1341-1381
-
-
Fox, K.1
Alonso Garcia, M.A.2
Ardissino, D.3
Buszman, P.4
Camici, P.G.5
Crea, F.6
Daly, C.7
De Backer, G.8
Hjemdahl, P.9
Lopez-Sendon, J.10
Marco, J.11
Morais, J.12
Pepper, J.13
Sechtem, U.14
Simoons, M.15
Thygesen, K.16
-
21
-
-
0042512336
-
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice
-
De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2003;24:1601-1610
-
(2003)
Eur Heart J
, vol.24
, pp. 1601-1610
-
-
De Backer, G.1
Ambrosioni, E.2
Borch-Johnsen, K.3
Brotons, C.4
Cifkova, R.5
Dallongeville, J.6
Al, E.7
-
22
-
-
38049033935
-
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: A meta-analysis
-
Kearney PM, Blackwell L, Collins R, Keech A, Simes J, Peto R, et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet. 2008;371:117-125
-
(2008)
Lancet
, vol.371
, pp. 117-125
-
-
Kearney, P.M.1
Blackwell, L.2
Collins, R.3
Keech, A.4
Simes, J.5
Peto, R.6
-
23
-
-
15944410609
-
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
-
LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352:1425-1435
-
(2005)
N Engl J Med
, vol.352
, pp. 1425-1435
-
-
Larosa, J.C.1
Grundy, S.M.2
Waters, D.D.3
Shear, C.4
Barter, P.5
Fruchart, J.C.6
-
24
-
-
34547970751
-
Safety and efficacy of atorvastatin-induced very low-density lipoprotein cholesterol levels in patients with coronary heart disease (a post hoc analysis of the Treating to New Targets (TNT) study)
-
LaRosa JC, Grundy SM, Kastelein JJ, Kostis JB, Greten H. Safety and efficacy of atorvastatin-induced very low-density lipoprotein cholesterol levels in patients with coronary heart disease (a post hoc analysis of the Treating to New Targets (TNT) study). Am J Cardiol. 2007;100:747-752
-
(2007)
Am J Cardiol
, vol.100
, pp. 747-752
-
-
Larosa, J.C.1
Grundy, S.M.2
Kastelein, J.J.3
Kostis, J.B.4
Greten, H.5
-
25
-
-
27744603499
-
High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: The IDEAL study: A randomized controlled trial
-
Pedersen TR, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Holme I, et al. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA. 2005;294:2437-2445
-
(2005)
JAMA
, vol.294
, pp. 2437-2445
-
-
Pedersen, T.R.1
Faergeman, O.2
Kastelein, J.J.3
Olsson, A.G.4
Tikkanen, M.J.5
Holme, I.6
-
26
-
-
11144355354
-
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
-
Cannon C, Braunwald E, McCabe C, Rader D, Rouleau J, Belder R, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495-1504
-
(2004)
N Engl J Med
, vol.350
, pp. 1495-1504
-
-
Cannon, C.1
Braunwald, E.2
McCabe, C.3
Rader, D.4
Rouleau, J.5
Belder, R.6
-
27
-
-
4544243333
-
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z trial
-
de Lemos JA, Blazing MA, Wiviott SD, Lewis EF, Fox KA, White HD, et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA. 2004;292:1307-1316
-
(2004)
JAMA
, vol.292
, pp. 1307-1316
-
-
De Lemos, J.A.1
Blazing, M.A.2
Wiviott, S.D.3
Lewis, E.F.4
Fox, K.A.5
White, H.D.6
-
28
-
-
33746355566
-
Meta-Analysis of Cardiovascular Outcomes Trials Comparing Intensive Versus Moderate Statin Therapy
-
DOI 10.1016/j.jacc.2006.04.070, PII S0735109706011752
-
Cannon CP, Steinberg BA, Murphy SA, Mega JL, Braunwald E. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol. 2006;48:438-445 (Pubitemid 44109954)
-
(2006)
Journal of the American College of Cardiology
, vol.48
, Issue.3
, pp. 438-445
-
-
Cannon, C.P.1
Steinberg, B.A.2
Murphy, S.A.3
Mega, J.L.4
Braunwald, E.5
-
29
-
-
34247479529
-
Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy
-
Silva M, Matthews ML, Jarvis C, Nolan NM, Belliveau P, Malloy M, et al. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy. Clin Ther. 2007;29:253-260
-
(2007)
Clin Ther
, vol.29
, pp. 253-260
-
-
Silva, M.1
Matthews, M.L.2
Jarvis, C.3
Nolan, N.M.4
Belliveau, P.5
Malloy, M.6
-
30
-
-
0037420492
-
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial
-
DOI 10.1016/S0140-6736(03)12948-0
-
Sever P, Dahlof B, PoulterN, Wedel H, Beevers G, Caulfield M, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial*Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet. 2003;361:1149-1158 (Pubitemid 36398384)
-
(2003)
Lancet
, vol.361
, Issue.9364
, pp. 1149-1158
-
-
Sever, P.S.1
Dahlof, B.2
Poulter, N.R.3
Wedel, H.4
Beevers, G.5
Caulfield, M.6
Collins, R.7
Kjeldsen, S.E.8
Kristinsson, A.9
McInnes, G.T.10
Mehlsen, J.11
Nieminen, M.12
O'Brien, E.13
Ostergren, J.14
-
31
-
-
56749106312
-
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
-
Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195-2207
-
(2008)
N Engl J Med
, vol.359
, pp. 2195-2207
-
-
Ridker, P.M.1
Danielson, E.2
Fonseca, F.A.3
Genest, J.4
Jr G.Am5
Kastelein, J.J.6
-
32
-
-
7044222840
-
Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: The alliance study
-
Koren MJ, Hunninghake DB. Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study. J Am Coll Cardiol. 2004;44:1772-1779
-
(2004)
J Am Coll Cardiol
, vol.44
, pp. 1772-1779
-
-
Koren, M.J.1
Hunninghake, D.B.2
-
33
-
-
25444485767
-
Differences between statins on clinical endpoints: A population-based cohort study
-
Dieleman JP, van Wyk JT, van Wijk MA, van Herpen G, Straus SM, Dunselman H, et al. Differences between statins on clinical endpoints: a population-based cohort study. Curr Med Res Opin. 2005;21:1461-1468
-
(2005)
Curr Med Res Opin
, vol.21
, pp. 1461-1468
-
-
Dieleman, J.P.1
Van Wyk, J.T.2
Van Wijk, M.A.3
Van Herpen, G.4
Straus, S.M.5
Dunselman, H.6
-
34
-
-
45149123632
-
Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin: A large database analysis of managed care plans in the US
-
Foody J, Joyce A, Rudolph A, Liu LZ, Benner J. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin: a large database analysis of managed care plans in the US. Clin Ther. 2008;30:195-205.
-
(2008)
Clin Ther
, vol.30
, pp. 195-205
-
-
Foody, J.1
Joyce, A.2
Rudolph, A.3
Liu, L.Z.4
Benner, J.5
-
35
-
-
16844382829
-
Pathological changes in acute coronary syndromes: The role of statin therapy in the modulation of inflammation, endothelial function and coagulation
-
Ray KK, Cannon CP. Pathological changes in acute coronary syndromes: the role of statin therapy in the modulation of inflammation, endothelial function and coagulation. J Thromb Thrombolysis. 2004;18:89-101.
-
(2004)
J Thromb Thrombolysis
, vol.18
, pp. 89-101
-
-
Ray, K.K.1
Cannon, C.P.2
-
36
-
-
33749002873
-
The effect of early, intensive statin therapy on acute coronary syndrome: A meta-analysis of randomized controlled trials
-
Hulten E, Jackson JL, Douglas K, George S, Villines TC. The effect of early, intensive statin therapy on acute coronary syndrome: a meta-analysis of randomized controlled trials. Arch Intern Med. 2006;166:1814-1821
-
(2006)
Arch Intern Med
, vol.166
, pp. 1814-1821
-
-
Hulten, E.1
Jackson, J.L.2
Douglas, K.3
George, S.4
Villines, T.C.5
-
37
-
-
0035804846
-
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial
-
Schwartz G, Olsson A, Ezekowitz M, Ganz P, Oliver M, Waters D, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2001;285:1711-1718
-
(2001)
JAMA
, vol.285
, pp. 1711-1718
-
-
Schwartz, G.1
Olsson, A.2
Ezekowitz, M.3
Ganz, P.4
Oliver, M.5
Waters, D.6
-
38
-
-
17944396864
-
Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: The Pravastatin in Acute Coronary Treatment (PACT) trial
-
Thompson PL, Meredith I, Amerena J, Campbell TJ, Sloman JG, Harris PJ. Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial. Am Heart J. 2004;148:e2.
-
(2004)
Am Heart J
, vol.148
-
-
Thompson, P.L.1
Meredith, I.2
Amerena, J.3
Campbell, T.J.4
Sloman, J.G.5
Harris, P.J.6
-
39
-
-
70749159902
-
The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome
-
Aug Epub ahead of print
-
Yun KH, Jeong MH, Oh SK, Rhee SJ, Park EM, Lee EM, et al. The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome. Int J Cardiol. 2008 Aug 13 (Epub ahead of print).
-
(2008)
Int J Cardiol
, vol.13
-
-
Yun, K.H.1
Jeong, M.H.2
Oh, S.K.3
Rhee, S.J.4
Park, E.M.5
Lee, E.M.6
-
40
-
-
0035820313
-
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: An observational study
-
Aronow HD, Topol EJ, Roe MT, Houghtaling PL, Wolski KE, Lincoff AM, et al. Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study. Lancet. 2001;357:1063-1068
-
(2001)
Lancet
, vol.357
, pp. 1063-1068
-
-
Aronow, H.D.1
Topol, E.J.2
Roe, M.T.3
Houghtaling, P.L.4
Wolski, K.E.5
Lincoff, A.M.6
-
41
-
-
17844406130
-
Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: Observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trial
-
Smith CS, Cannon CP, McCabe CH, Murphy SA, Bentley J, Braunwald E. Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trial. Am Heart J. 2005;149:444-450
-
(2005)
Am Heart J
, vol.149
, pp. 444-450
-
-
Smith, C.S.1
Cannon, C.P.2
McCabe, C.H.3
Murphy, S.A.4
Bentley, J.5
Braunwald, E.6
-
42
-
-
0001276528
-
Early statin therapy is associated with markedly lower mortality in patients with acute coronary syndromes: Observations from OPUS-TIMI 16 [Abstract]
-
Cannon C, McCabe C, Bentley J, Braunwald E. Early statin therapy is associated with markedly lower mortality in patients with acute coronary syndromes: Observations from OPUS-TIMI 16 [Abstract]. J Am Coll Cardiol. 2001;37 Suppl:A334.
-
(2001)
J Am Coll Cardiol
, vol.37
, Issue.SUPPL.
-
-
Cannon, C.1
McCabe, C.2
Bentley, J.3
Braunwald, E.4
-
43
-
-
0035941512
-
Early statin treatment following acute myocardial infarction and 1-year survival
-
Stenestrand U, Wallentin L. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA. 2001;285:430-436
-
(2001)
JAMA
, vol.285
, pp. 430-436
-
-
Stenestrand, U.1
Wallentin, L.2
-
44
-
-
2542422856
-
Association of statin therapy with outcomes of acute coronary syndromes: The GRACE study
-
Spencer FA, Allegrone J, Goldberg RJ, Gore JM, Fox KA, Granger CB, et al. Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. Ann Intern Med. 2004;140:857-866
-
(2004)
Ann Intern Med
, vol.140
, pp. 857-866
-
-
Spencer, F.A.1
Allegrone, J.2
Goldberg, R.J.3
Gore, J.M.4
Fox, K.A.5
Granger, C.B.6
-
45
-
-
23944497531
-
Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality
-
Fonarow GC, Wright RS, Spencer FA, Fredrick PD, Dong W, Every N, et al. Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. Am J Cardiol. 2005;96:611-616
-
(2005)
Am J Cardiol
, vol.96
, pp. 611-616
-
-
Spencer, F.A.1
Goldberg, R.J.2
Gore, J.M.3
Fox, K.A.4
Avezum, A.5
Agnelli, G.6
Al, E.7
-
46
-
-
29244483080
-
Comparative safety of atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients
-
Newman C, Tsai J, Szarek M, Luo D, Gibson E. Comparative safety of atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients. Am J Cardiol. 2006;97:61-67
-
(2006)
Am J Cardiol
, vol.97
, pp. 61-67
-
-
Newman, C.1
Tsai, J.2
Szarek, M.3
Luo, D.4
Gibson, E.5
-
47
-
-
44049091020
-
Clinical efficacy and safety of statins in managing cardiovascular risk
-
Kapur NK, Musunuru K. Clinical efficacy and safety of statins in managing cardiovascular risk. Vasc Health Risk Manag. 2008;4:341-353
-
(2008)
Vasc Health Risk Manag
, vol.4
, pp. 341-353
-
-
Kapur, N.K.1
Musunuru, K.2
-
48
-
-
57649162585
-
The safety of rosuvastatin in comparison with other statins in over 25,000 statin users in the Saskatchewan Health Databases
-
Garcia-Rodriguez LA, Gonzalez-Perez A, Stang MR, Wal-lander MA, Johansson S. The safety of rosuvastatin in comparison with other statins in over 25,000 statin users in the Saskatchewan Health Databases. Pharmacoepidemiol Drug Saf. 2008;17:953-961
-
(2008)
Pharmacoepidemiol Drug Saf
, vol.17
, pp. 953-961
-
-
Garcia-Rodriguez, L.A.1
Gonzalez-Perez, A.2
Stang, M.R.3
Wal-Lander, M.A.4
Johansson, S.5
-
49
-
-
53549104055
-
The safety of rosuvastatin in comparison with other statins in over 100,000 statin users in UK primary care
-
Garcia-Rodriguez LA, Masso-Gonzalez EL, Wallander MA, Johansson S. The safety of rosuvastatin in comparison with other statins in over 100,000 statin users in UK primary care. Pharmacoepidemiol Drug Saf. 2008;17:943-952
-
(2008)
Pharmacoepidemiol Drug Saf
, vol.17
, pp. 943-952
-
-
Garcia-Rodriguez, L.A.1
Masso-Gonzalez, E.L.2
Wallander, M.A.3
Johansson, S.4
-
50
-
-
34447627450
-
Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: Insights from large randomized statin trials
-
Alsheikh-Ali AA, Maddukuri PV, Han H, Karas RH. Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials. J Am Coll Cardiol. 2007;50:409-418
-
(2007)
J Am Coll Cardiol
, vol.50
, pp. 409-418
-
-
Alsheikh-Ali, A.A.1
Maddukuri, P.V.2
Han, H.3
Karas, R.H.4
-
51
-
-
33846111227
-
Statins and the risk of lung, breast, and colorectal cancer in the elderly
-
Setoguchi S, Glynn RJ, Avorn J, Mogun H, Schneeweiss S. Statins and the risk of lung, breast, and colorectal cancer in the elderly. Circulation. 2007;115:27-33.
-
(2007)
Circulation
, vol.115
, pp. 27-33
-
-
Setoguchi, S.1
Glynn, R.J.2
Avorn, J.3
Mogun, H.4
Schneeweiss, S.5
-
52
-
-
34248196018
-
Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease
-
Chan PS, Nallamothu BK, Gurm HS, Hayward RA, Vijan S. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease. Circulation. 2007;115:2398-2409
-
(2007)
Circulation
, vol.115
, pp. 2398-2409
-
-
Chan, P.S.1
Nallamothu, B.K.2
Gurm, H.S.3
Hayward, R.A.4
Vijan, S.5
-
53
-
-
28044454022
-
Cost-effectiveness of intensive therapy in patients with acute coronary syndrome [Abstract]
-
Koren M, Schwartz S, Drummond M. Cost-effectiveness of intensive therapy in patients with acute coronary syndrome [Abstract]. J Am Coll Cardiol. 2005;45:347A.
-
(2005)
J Am Coll Cardiol
, vol.45
-
-
Koren, M.1
Schwartz, S.2
Drummond, M.3
-
54
-
-
70350476997
-
Cost-effectiveness of intensive lipid-lowering treatment in secondary cardiovascular prevention in Spain and Germany [Abstract]
-
Taylor D, Pandya A, Thompson D, Chu P, Graff J, LaRosa J, et al. Cost-effectiveness of intensive lipid-lowering treatment in secondary cardiovascular prevention in Spain and Germany [Abstract]. Atheroscler Suppl. 2007;8:125.
-
(2007)
Atheroscler Suppl
, vol.8
, pp. 125
-
-
Taylor, D.1
Pandya, A.2
Thompson, D.3
Chu, P.4
Graff, J.5
Larosa, J.6
-
55
-
-
34548316230
-
Cost-effectiveness of high-dose atorvastatin compared with regular dose simvastatin
-
Lindgren P, Graff J, Olsson AG, Pedersen TJ, Jonsson B. Cost-effectiveness of high-dose atorvastatin compared with regular dose simvastatin. Eur Heart J. 2007;28:1448-1453
-
(2007)
Eur Heart J
, vol.28
, pp. 1448-1453
-
-
Lindgren, P.1
Graff, J.2
Olsson, A.G.3
Pedersen, T.J.4
Jonsson, B.5
-
56
-
-
34547210808
-
Economic impacts attributable to the early clinical benefit of atorvastatin therapy*a US managed care perspective
-
Straka RJ, Mamdani M, Damen J, Kuntze CE, Liu LZ, Botteman MF, et al. Economic impacts attributable to the early clinical benefit of atorvastatin therapy*a US managed care perspective. Curr Med Res Opin. 2007;23:1517-1529
-
(2007)
Curr Med Res Opin
, vol.23
, pp. 1517-1529
-
-
Straka, R.J.1
Mamdani, M.2
Damen, J.3
Kuntze, C.E.4
Liu, L.Z.5
Botteman, M.F.6
-
57
-
-
38049084305
-
Cost-effectiveness analysis of atorvastatin compared to simvastatin treatment in Greece
-
Yfantopoulos J, Papagiannopoulou V. Cost-effectiveness analysis of atorvastatin compared to simvastatin treatment in Greece. Arch Hel Med. 2007;24:463-470
-
(2007)
Arch Hel Med
, vol.24
, pp. 463-470
-
-
Yfantopoulos, J.1
Papagiannopoulou, V.2
-
58
-
-
53749086313
-
Statin cost-effectiveness comparisons using real-world effectiveness data: Formulary implications
-
Ohsfeldt RL, Gandhi SK, Fox KM, McKenney JM. Statin cost-effectiveness comparisons using real-world effectiveness data: formulary implications. Value Health. 2008;11:1061-1069
-
(2008)
Value Health
, vol.11
, pp. 1061-1069
-
-
Ohsfeldt, R.L.1
Gandhi, S.K.2
Fox, K.M.3
McKenney, J.M.4
-
59
-
-
41949105051
-
Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: Rosuvastatin compared with other statins in usual care
-
Harley CR, Gandhi SK, Heien H, McDonough K, Nelson SP. Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care. Expert Opin Pharmacother. 2008;9:669-676
-
(2008)
Expert Opin Pharmacother
, vol.9
, pp. 669-676
-
-
Harley, C.R.1
Gandhi, S.K.2
Heien, H.3
McDonough, K.4
Nelson, S.P.5
-
61
-
-
27744549370
-
The effect of switching on compliance and persistence: The case of statin treatment
-
Thiebaud P, Patel BV, Nichol MB, Berenbeim DM. The effect of switching on compliance and persistence: the case of statin treatment. Am J Manag Care. 2005;11:670.
-
(2005)
Am J Manag Care
, vol.11
, pp. 670
-
-
Thiebaud, P.1
Patel, B.V.2
Nichol, M.B.3
Berenbeim, D.M.4
-
62
-
-
34547822507
-
Therapeutic dose assessment of patient switching from atorvastatin to simvastatin
-
Hess G, Sanders KN, Hill J, Liu LZ. Therapeutic dose assessment of patient switching from atorvastatin to simvastatin. Am J Manag Care. 2007;13 Suppl 3:S80-5.
-
(2007)
Am J Manag Care
, vol.13
, Issue.SUPPL. 3
-
-
Hess, G.1
Sanders, K.N.2
Hill, J.3
Liu, L.Z.4
-
63
-
-
37849044165
-
Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting
-
Fox KM, Gandhi SK, Ohsfeldt RL, Davidson MH. Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting. Am J Manag Care. 2007;13 Suppl 10:S270-5.
-
(2007)
Am J Manag Care
, vol.13
, Issue.SUPPL. 10
-
-
Fox, K.M.1
Gandhi, S.K.2
Ohsfeldt, R.L.3
Davidson, M.H.4
-
64
-
-
36849056965
-
Switching statins: The impact on patient outcomes
-
Phillips B, Aziz F, O'Regan C, Roberts C, Rudolph A, Morant S. Switching statins: the impact on patient outcomes. Br J Cardiol. 2007;14:280-285
-
(2007)
Br J Cardiol
, vol.14
, pp. 280-285
-
-
Phillips, B.1
Aziz, F.2
O'Regan, C.3
Roberts, C.4
Rudolph, A.5
Morant, S.6
-
65
-
-
0032488379
-
Increased thrombotic vascular events after change of statin
-
Thomas M, Mann J. Increased thrombotic vascular events after change of statin. Lancet. 1998;352:1830-1831
-
(1998)
Lancet
, vol.352
, pp. 1830-1831
-
-
Thomas, M.1
Mann, J.2
-
66
-
-
33845892767
-
Cholesterol lowering in patients with CHD and metabolic syndrome [Letter]
-
Butler R, Wainwright J. Cholesterol lowering in patients with CHD and metabolic syndrome [Letter]. Lancet. 2007;369:27.
-
(2007)
Lancet
, vol.369
, pp. 27
-
-
Butler, R.1
Wainwright, J.2
-
67
-
-
4344679110
-
Long term persistence with statin treatment in daily medical practice
-
Mantel-Teeuwisse AK, Goettsch WG, Klungel OH, de Boer A, Herings RM. Long term persistence with statin treatment in daily medical practice. Heart. 2004;90:1065-1066
-
(2004)
Heart
, vol.90
, pp. 1065-1066
-
-
Mantel-Teeuwisse, A.K.1
Goettsch, W.G.2
Klungel, O.H.3
De Boer, A.4
Herings, R.M.5
-
68
-
-
22444437849
-
Association between short-term effectiveness of statins and long-term adherence to lipid-lowering therapy
-
Benner JS, Pollack MF, Smith TW, Bullano MF, Willey VJ, Williams SA. Association between short-term effectiveness of statins and long-term adherence to lipid-lowering therapy. Am J Health Syst Pharm. 2005;62:1468-1475
-
(2005)
Am J Health Syst Pharm
, vol.62
, pp. 1468-1475
-
-
Benner, J.S.1
Pollack, M.F.2
Smith, T.W.3
Bullano, M.F.4
Willey, V.J.5
Williams, S.A.6
-
69
-
-
43949093826
-
Can cheap generic statins achieve national cholesterol lowering targets?
-
Petty D, Lloyd D. Can cheap generic statins achieve national cholesterol lowering targets? J Health Serv Res Policy. 2008;13:99-102.
-
(2008)
J Health Serv Res Policy
, vol.13
, pp. 99-102
-
-
Petty, D.1
Lloyd, D.2
-
70
-
-
38849113845
-
Evaluation of the clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a primary care setting: 2 years on
-
Usher-Smith J, Ramsbottom T, Pearmain H, Kirby M. Evaluation of the clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a primary care setting: 2 years on. Int J Clin Pract. 2008;62:480.
-
(2008)
Int J Clin Pract
, vol.62
, pp. 480
-
-
Usher-Smith, J.1
Ramsbottom, T.2
Pearmain, H.3
Kirby, M.4
-
71
-
-
33847028362
-
Evaluation of the cost savings and clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a primary care setting
-
Usher-Smith JA, Ramsbottom T, Pearmain H, Kirby M. Evaluation of the cost savings and clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a primary care setting. Int J Clin Pract. 2007;61:15-23.
-
(2007)
Int J Clin Pract
, vol.61
, pp. 15-23
-
-
Usher-Smith, J.A.1
Ramsbottom, T.2
Pearmain, H.3
Kirby, M.4
-
72
-
-
42949138132
-
Switching statin therapy using a pharmacist-managed therapeutic conversion program versus usual care conversion among indigent patients
-
Miller AE, Hansen LB, Saseen JJ. Switching statin therapy using a pharmacist-managed therapeutic conversion program versus usual care conversion among indigent patients. Pharmacotherapy. 2008;28:553-561
-
(2008)
Pharmacotherapy
, vol.28
, pp. 553-561
-
-
Miller, A.E.1
Hansen, L.B.2
Saseen, J.J.3
|